Find High-Quality Human Biospecimens
Whatever type of biospecimens you need, whether from a prospective collection or our in-house inventory, you can order with the full confidence of our quality guarantee.
Tissues
Find fresh, FFPE (embedded) and flash-frozen tissues from donors with a range of diseases or from healthy tissue.
Peripheral Blood Products
Choose from our inventory of whole blood, serum, and plasma or request a prospective collection.
Cells
Order PBMCs, BMMCs, and dissociated tumor cells (DTCs) from healthy and disease-state donors.
Biofluids
Access a full range of biofluids, including urine, synovial fluid, CSF, BAL, saliva and more.
Advance Insight Across Multiple Indications
The high quality human biospecimens offered by Audubon Bioscience support a wide range of disease indications, including:
- Oncology
- COVID-19
- Benign Tumors
- Hematology
- Dermatology
- Rheumatology
Quality Guarantee
If we don't deliver on this promise to your satisfaction our replacement service will be free of charge
- High Quality
Your sample and data integrity are of utmost importance to us. High quality procurement, temperature control and sample delivery are ensured to meet your project's standards. - Strict Compliance
We guarantee that ethical, biomedical and environmental regulations are in place and assured while handling all biospecimens and their associated data. - Maximum Flexibility
We recognize that every project has specific details and no two projects are alike. We ensure to meet your requirements by being flexible to fit your project’s specifications. - Donor Respect
We vow to never forget that all biospecimen donations and their associated data originate from a patient. It is our duty to make sure these samples are treated with respect. - Kept Timelines
We understand that your projects are time-sensitive so we promise to execute your project collection within the strictly agreed timelines.
Global Network of Clinic Locations
120+
Clinical Sites
12
Countries
4
Continents
Latest News
Updates from our Blog
While there is still much work to be done in the fight against cancer, the progress made at this year's meeting is cause for hope and optimism. As researchers continue to collaborate and innovate, Audubon Bioscience continues to commit itself to supporting the development of these patient-derived biospecimens, ensuring their prospective procurement and logistics to clinics and research institutes.
While biospecimens have convincingly gained their place as key building blocks for the advancement of biomedical research, their full potential, collections design, and regulatory requirements are often not well understood. As the sophistication of biopharmaceutical research and progress are constantly increasing, so is the complexity of biosamples collection projects.